URTICARIA pigmentosa, a chronic benign cutaneous disorder occurring at all ages, is characterized clinically by pigmented macules, papules or, rarely, nodules, and microscopically by an increased ...

Cemento-osseous dysplasia (COD) and related fibro-osseous lesions represent a diverse group of benign conditions affecting the jaw and craniofacial bones. These lesions are characterised by the ...

Osseous sarcoidosis is an uncommon manifestation of sarcoidosis that can mimic metastatic bone disease on imaging. Both osseous sarcoidosis and bone metastases from breast cancer can present as lytic, ...

Juvenile psammomatoid ossifying fibroma (JPOF) represents a distinct subtype within the broader spectrum of fibro-osseous lesions, which are characterised by the replacement of normal bone with ...

Please provide your email address to receive an email when new articles are posted on . A 44-year-old man was referred for evaluation of hypercalcemia. He had atraumatic rib and clavicle fractures in ...

Patients with multiple myeloma often develop bone lesions resulting in skeletal-related events (SREs), such as spinal cord compression, vertebral collapse, pathologic fractures and bone pain. Bone ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

A new study shows lesions, which can best be seen on MRI scans, could help identify individuals who are more likely to suffer from more rapidly progressing osteoarthritis. Osteoarthritis is the most ...

Please provide your email address to receive an email when new articles are posted on . A 54-year-old man with squamous cell carcinoma of the lung with lymph node and osseous metastases underwent ...

(Reuters) - Regeneron Pharmaceuticals Inc said on Thursday its experimental treatment for a very rare genetic bone disorder showed a nearly 90% reduction in new lesions compared to placebo, in a ...

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients. These ...